Clinical Outcomes of Patients with Rare and Heavily Pretreated Solid Tumors Treated according to the Results of Tumor Molecular Profiling

Figure 2

PFS with therapy suggested by MP versus that with prior line of therapy. The ratio between these two values is also shown.